Olimel 5.7% E 1.50 g

OlimeL 5.7% E 1.50 G is an intravenous emulsion containing sodium acetate trihydrate. It is used to provide essential electrolytes for patients requiring parenteral nutrition. This product is manufactured by Baxter Corporation in Canada.

OlimeL 5.7% E 1.50 G is primarily used to supply sodium acetate, an electrolyte, to patients who cannot absorb nutrients through the digestive system. This intravenous emulsion is often part of a broader nutritional support plan. It helps maintain electrolyte balance, which is crucial for various bodily functions, including nerve and muscle activity.

When administered intravenously, OlimeL 5.7% E 1.50 G provides sodium acetate, which helps to regulate fluid balance and support metabolic processes. Patients may experience improved electrolyte levels, which can contribute to overall well-being. However, individual responses can vary.

OlimeL 5.7% E 1.50 G should be administered under medical supervision. It is essential to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

OlimeL 5.7% E 1.50 G may interact with other medications or supplements. It is important to inform healthcare providers about all current treatments to avoid potential interactions. Specific interactions can vary based on individual health conditions and other medications being taken.